Growth Metrics

Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026)

Verastem's quarterly Total Non-Current Liabilities came in at $146.0 million in Q1 2026, up 33.5% year-on-year from $109.4 million in Q1 2025, and down 4.93% quarter-over-quarter from $153.6 million in Q4 2025.

Verastem has reported Total Non-Current Liabilities for 12 years, with the latest figure at $146.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 33.5% year-over-year to $146.0 million; the trailing twelve-month figure through Mar 2026 stood at $146.0 million (up 33.5% YoY), and the FY2025 full-year result was $153.6 million, up 112.65% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $146.0 million, down from $153.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $153.6 million in Q4 2025, with the low at $68.0 million in Q3 2024.
  • Average Total Non-Current Liabilities over 4 years is $114.7 million, with a median of $126.7 million recorded in 2025.
  • Year-over-year, Total Non-Current Liabilities decreased 5.21% in 2024 and surged 112.65% in 2025.
  • Tracing VSTM's Total Non-Current Liabilities over 4 years: stood at $71.8 million in 2023, then climbed by 0.65% to $72.2 million in 2024, then surged by 112.65% to $153.6 million in 2025, then decreased by 4.93% to $146.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $146.0 million (Q1 2026), $153.6 million (Q4 2025), and $144.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 11.03 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 42,980.09
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 110.28 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.05 Bn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 146.03 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 146.03 Mn
Dec 31, 2025 153.60 Mn
Sep 30, 2025 144.09 Mn
Jun 30, 2025 152.66 Mn
Mar 31, 2025 109.39 Mn
Dec 31, 2024 72.23 Mn
Sep 30, 2024 68.02 Mn
Sep 30, 2023 71.76 Mn
Jun 30, 2020 83.29 Mn
Mar 31, 2020 84.30 Mn
Dec 31, 2019 137.00 Mn
Sep 30, 2019 170.21 Mn
Jun 30, 2019 168.73 Mn
Mar 31, 2019 154.41 Mn
Dec 31, 2018 151.81 Mn
Sep 30, 2018 74.98 Mn
Jun 30, 2018 45.65 Mn
Mar 31, 2018 29.76 Mn
Dec 31, 2017 31.96 Mn
Sep 30, 2017 21.95 Mn
Jun 30, 2017 13.36 Mn
Mar 31, 2017 15.48 Mn
Dec 31, 2016 11.33 Mn
Sep 30, 2016 6.22 Mn
Jun 30, 2016 5.93 Mn
Mar 31, 2016 6.12 Mn
Dec 31, 2015 10.11 Mn
Sep 30, 2013 5.71 Mn
Dec 31, 2012 2.40 Mn